Package 60687-720-21

{"route": ["ORAL"], "spl_id": "223f034f-e646-cd65-e063-6394a90a3505", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199147"], "spl_set_id": ["7ad3a998-8e4d-43a0-8930-8f7a6ae539b4"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (60687-720-21)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-720-11)", "package_ndc": "60687-720-21", "marketing_start_date": "20230119"}], "brand_name": "Lamivudine", "product_id": "60687-720_223f034f-e646-cd65-e063-6394a90a3505", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "60687-720", "generic_name": "Lamivudine", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "ANDA091606", "marketing_category": "ANDA", "marketing_start_date": "20230119", "listing_expiration_date": "20261231"}